These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 13254089)
21. [Blood substitution in the newborn with erythroblastosis]. LEIVA COFRE H; SCHEPELER VM Rev Chil Pediatr; 1947 Oct; 18(10):733-55. PubMed ID: 18904699 [No Abstract] [Full Text] [Related]
22. [Maternal prevention of hemolytic disease of the newborn]. PACI S Clin Ginecol; 1961; 3():269-84. PubMed ID: 14483054 [No Abstract] [Full Text] [Related]
23. INTRAUTERINE TRANSFUSION OF FOETUS IN HAEMOLYTIC DISEASE. LILEY AW Br Med J; 1963 Nov; 2(5365):1107-9. PubMed ID: 14057715 [No Abstract] [Full Text] [Related]
24. [Blood groups and transfusions]. BRAY G Rev Belge Stomatol; 1953 Jun; 50(2):199-223. PubMed ID: 13101076 [No Abstract] [Full Text] [Related]
25. Organization of the fight against hemolytic disease of the newborn. MOUREAU P; GOSSELIN O; LEGROS J Brux Med; 1952 Dec; 32(50):2613-6. PubMed ID: 13019267 [No Abstract] [Full Text] [Related]
26. [Organization of the fight against the hemolytic disease of the newborn]. MOUREAU-GOSSELIN ; LEGROS Concours Med; 1953 Apr; 75(16):1445-6. PubMed ID: 13067550 [No Abstract] [Full Text] [Related]
27. [Prevention of hemolytic disease of the newborn with cortisone]. CORELLI F; SICILIANO G Policlinico Prat; 1952 Nov; 59(45):1485-90. PubMed ID: 13026507 [No Abstract] [Full Text] [Related]
28. Experimental studies on the prevention of Rh haemolytic disease. FINN R; CLARKE CA; DONOHOE WT; McCONNELL RB; SHEPPARD PM; LEHANE D; KULKE W Br Med J; 1961 May; 1(5238):1486-90. PubMed ID: 13699661 [No Abstract] [Full Text] [Related]
29. Replacement transfusion as a means of preventing kernicterus of prematurity. CROSSE VM; WALLIS PG; WALSH AM Arch Dis Child; 1958 Oct; 33(171):403-8. PubMed ID: 13584018 [No Abstract] [Full Text] [Related]
31. [Pathogenesis of hemolytic disease; importance of blood transfusion and of breast feeding]. FORMAGGIO TG; BASSI L Acta Paediatr Lat; 1952; 5(5):458-72. PubMed ID: 12996307 [No Abstract] [Full Text] [Related]
33. [Clinical contribution to the therapy of nuclear jaundice of the newborn; new procedure of replacement transfusion]. MASCIO A Minerva Ginecol; 1950 Oct; 2(10):425-34. PubMed ID: 14806152 [No Abstract] [Full Text] [Related]
34. [Cooperation of obstetrician and pediatrician in the treatment of morbus haemolyticus neonatorum]. HEMPEL HC Dtsch Gesundheitsw; 1956 Dec; 11(50):1713-9. PubMed ID: 24544249 [No Abstract] [Full Text] [Related]
35. [Tests for selection of blood donors in cases of hemolytic disease of the newborn]. SPEISER P; GRABNER G Klin Med Osterr Z Wiss Prakt Med; 1950 Nov; 5(11):499-506. PubMed ID: 14795627 [No Abstract] [Full Text] [Related]
36. [Indications for exsanguino-transfusion outside hemolytic disease of newborn]. BESSIS M; BERNARD J Sang; 1948; 19(1):40-5. PubMed ID: 18902584 [No Abstract] [Full Text] [Related]
38. Possible prevention of anti-A isosensitization disease by desensitization of the mother with substance A. FLYNN JE Am J Clin Pathol; 1952 May; 22(5):418-23. PubMed ID: 14923630 [No Abstract] [Full Text] [Related]
39. [Immunohematological study of the unit for prevention of neonatal hemolytic disease (N.H.D) at the Ospedale di Varese]. CARRERA F Riv Ostet Ginecol Prat; 1961 Jun; 43():457-63. PubMed ID: 15445159 [No Abstract] [Full Text] [Related]
40. Liquor amnii studies in the prediction of haemolytic disease of the newborn. WALKER AH Br Med J; 1957 Aug; 2(5041):376-8. PubMed ID: 13446487 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]